ALLIANCEBERNSTEIN L.P. - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 58 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$332,000
-42.9%
60,200
+0.3%
0.00%
Q4 2021$581,000
-45.9%
60,0000.0%0.00%
Q3 2021$1,073,000
-30.3%
60,000
-4.9%
0.00%
-100.0%
Q2 2021$1,540,000
-1.8%
63,100
+6.6%
0.00%0.0%
Q1 2021$1,569,000
+165.0%
59,200
-24.1%
0.00%
Q4 2020$592,000
+45.5%
78,000
-3.9%
0.00%
Q3 2020$407,000
-18.3%
81,200
-2.5%
0.00%
Q2 2020$498,000
+61.7%
83,300
+20.4%
0.00%
Q1 2020$308,000
-28.7%
69,200
+52.1%
0.00%
Q4 2019$432,000
-98.0%
45,500
-98.4%
0.00%
-100.0%
Q3 2019$22,094,000
-44.1%
2,814,572
+12.0%
0.01%
-44.0%
Q2 2019$39,521,000
-12.7%
2,512,452
+0.5%
0.02%
-13.8%
Q1 2019$45,268,000
+23.3%
2,501,014
+9.5%
0.03%
+7.4%
Q4 2018$36,727,000
-5.9%
2,284,047
+40.4%
0.03%
+8.0%
Q3 2018$39,045,0001,626,8550.02%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,618,351$11,652,00019.67%
Flagship Pioneering Inc. 38,296,526$170,419,0007.99%
HARBOURVEST PARTNERS LLC 986,878$4,392,0002.12%
Abbot Financial Management, Inc. 563,500$2,508,0002.04%
Artal Group S.A. 3,883,791$17,283,0000.73%
ARK Investment Management 318,121$1,416,0000.04%
Walleye Capital LLC 34,000$151,0000.03%
Tekla Capital Management LLC 155,982$694,0000.03%
Baillie Gifford 4,256,900$18,943,0000.02%
FEDERATED HERMES, INC. 600,000$2,670,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders